PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 6/26

PharmD_KS's avatar
PharmD_KS
Jun 25, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 6/21

Today was really all about NQ. It had to sustain its break above 29923-29943 or risk a “meaningful unravel” which turned out to be a bit of an understatement if anything. This is the importance of properly understanding ranges. The failed break of the range opened a complete unravel back to yesterday’s low on NQ and it came within 30 points of it.

The 923-943 level had initially held low of night and was the long setup for the day, producing a 300+ rally to the weekly 30269-30293. NQ opened right at the FOMC VWAP and sold straight down back to the major weekly 29302-29339 level.

Note what happened when the 2nd 30-minute candle of the day opened. NQ traded straight higher 400+ handles. This is something to carry forward. Meaningful changes often take place at the open of a fresh 30-minute period.

ES traded to and through yesterday’s low, before triggering a LBAF which resolved for 80+ handles before ultimately failing just above last week’s low.

In the premarket update I had pondered if perhaps this was a selling opportunity for those still working off over leverage in semis.

This appears to have been the case, and the question now is whether or not they are don.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture